JP Morgan Maintains Overweight on Privia Health Gr, Raises Price Target to $32
Benzinga Newsdesk 1 year ago
NewsPrice TargetAnalyst Ratings
JP Morgan analyst Lisa Gill maintains Privia Health Gr (NASDAQ:PRVA) with a Overweight and raises the price target from $29 to $32.
JP Morgan analyst Lisa Gill maintains Privia Health Gr (NASDAQ:PRVA) with a Overweight and raises the price target from $29 to $32.